Global Liver Transplantation Market Insights Forecasts to 2033

• The Global Liver Transplantation Market Size Was Estimated at USD 1.60 Billion in 2023
• The Market Size is Expected to Grow at a CAGR of around 6.62% from 2023 to 2033
• The Worldwide Liver Transplantation Market Size is Expected to Reach USD 3.04 Billion by 2033
• Asia Pacific is predicted to grow at the fastest CAGR throughout the projection period

The Global Liver Transplantation Market Size is Anticipated to Exceed USD 3.04 Billion by 2033, Growing at a CAGR of 6.62% from 2023 to 2033. The market growth is driven by the increasing prevalence of liver diseases including cirrhosis and hepatocellular carcinoma, sophisticated surgical techniques, organ preservation technologies, and extensive use of immunosuppressive drugs.

Market Overview

The liver transplantation market involves medical procedures, technologies, and services for end-stage liver disease or acute failure, including organ procurement, surgical procedures, post-transplant care, immunosuppressive drugs, and preservation technologies. Liver transplantation is a surgical process in which an injured liver is removed and replaced with a healthy liver from the donor. The most recommended method by healthcare professionals is orthotopic transplant (OLT) for liver transplantation.

The increasing liver diseases such as cirrhosis burden has increased the need for liver transplantation (LT), with global rates increasing by 20% in 2021. In the US, liver transplantation has increased by 18% in the last five years, with the majority of transplants occurring among living donors. In the US, 4.3% of LT used living donors in 2020.

Several government initiatives and schemes driving the demand for liver transplantation. For example, The National Organ Transplant Programme provides monthly financial assistance of Rs.6,000 to 100 needy and poor patients in Government hospitals for immunosuppressant therapy and liver transplantation under Rashtriya Arogya Nidhi.

Government investing in research centers for liver transplantation of patients belonging to the Gujarat region escalating the need for liver transplantation. For instance, Gujarat's state government provides financial assistance for liver transplantation to under-18-year-olds, SC/ST patients, and BPL card holders, with prior approval.

The liver transplantation market is witnessing a significant transition owing to the emergence of AI-based technologies and minimally invasive techniques in organ integration and post-operative care.

Report Coverage

This research report categorizes the global liver transplantation market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global liver transplantation market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global liver transplantation market.

Driving Factors:

The market for liver transplantation is anticipated to expand owing to the rise in the incidence of hepatitis A, B, and C globally. The development of new treatments and their growing acceptance as an ideal approach to treating end-stage liver disease are factors propelling the liver transplantation market.

The proliferation of sedentary lifestyles that adversely impact the liver, including unhealthy dietary habits, excessive drinking, and using illicit drugs, results in market expansion. Additionally, the need for liver transplants has increased in different regions owing to the scaling aging population and various manifestations of liver failure in the entire globe. The market is also expected to grow due to favorable reimbursement policies and the increasing popularity of organ transplantation as a treatment for organ failure. Bile duct cancer and alcoholic liver disease have significantly increased the need for liver transplants.

Restraining Factors

Risks that may restrict the liver transplantation market's growth and affect its profitability include severe bleeding, potentially fatal responses, diabetes, high cholesterol, diarrhea, and expensive hospital stays.

Market Segmentation

The global liver transplantation market share is classified into treatment type and end-user.

• The liver transplantation surgery segment dominated the market with 56.82% of the share in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period.

Based on the treatment type, the global liver transplantation market is categorized into post-surgery anti-rejection treatment, liver transplantation surgery, cyclosporine, tacrolimus, sirolimus, and others. Among these, the liver transplantation surgery segment dominated the market with 56.82% of the share in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period. The segment growth is attributed to patient compliance, definitive solutions for liver diseases, longer survival of patients, lower infection risk, and 3D perspective of the operating field makes it easy for physicians to visualize clearly during the transplantation for better outcomes, most preferred over medications, and patients’ expecting for aesthetic livings. The most common type of liver transplantation surgery is orthotopic liver transplantation.

• The hospitals segment accounted for the largest market share of 48.19% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.

Based on the end-user, the global liver transplantation market is categorized into ambulatory surgical centers, hospitals, transplant centers, and others. Among these, the hospitals segment accounted for the largest market share of 48.19% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segmental expansion is owing to the availability of highly qualified surgeons, and the presence of highly sophisticated facilities, enabling rehabilitation and physical therapy, personalized care, precision medicine, provision of government beneficiary schemes, availability of critical care units, and provision of the ambulance for emergency cases.

Regional Segment Analysis of the Global Liver Transplantation Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global liver transplantation market over the predicted timeframe.

North America is anticipated to hold the largest share of the global liver transplantation market over the forecast period. North America leads in liver transplantation owing to advanced healthcare infrastructure, high awareness, and favorable reimbursement policies. The US contributes significantly, performing over 9,234 liver transplants annually and Canada promotes liver health and donation through awareness campaigns.

Asia Pacific is anticipated to grow at the fastest CAGR throughout the projected timeframe. This is owing to rapid growth in healthcare infrastructure, higher spending, government initiatives, rising public awareness, and the expanding medical tourism sector in developing countries including China and India.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global liver transplantation market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Thompson Surgical
• Baxter Internation Inc.
• Vital Therapeutics
• Digna Biotech S.L.
• Allosource
• Conatus Pharmaceuticals
• Dompe Farmaceutici S.p.A
• RedHill Biopharma Ltd.
• Integra Lifesciences
• Humedics
• Isogenis, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In September 2023, UC Davis Health launched a new adult liver program. The move expands the existing services of the UC Davis Transplant Center and provides comprehensive care to patients with liver disease.

Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global liver transplantation market based on the below-mentioned segments:

Global Liver Transplantation Market, By Treatment Type

• Post Surgery Anti-Rejection Treatment
• Liver Transplantation Surgery
• Cyclosporine
• Tacrolimus
• Sirolimus
• Others

Global Liver Transplantation Market, By End-User

• Ambulatory Surgical Centers
• Hospitals
• Transplant Centers
• Others

Global Liver Transplantation Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East and Africa